Morgan Stanley
Morgan Stanley (MS-PQ) Financial Performance & Income Statement Overview
Analyze Morgan Stanley (MS-PQ) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Morgan Stanley (MS-PQ) Income Statement & Financial Overview
Review Morgan Stanley MS-PQ income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | -$12.82B | $27.91B | $25.98B | $26.33B |
| Cost of Revenue | $11.53B | $11.53B | $11.05B | $12.07B |
| Gross Profit | -$16.38B | $16.38B | $14.93B | $14.26B |
| Gross Profit Ratio | $1.28 | $0.59 | $0.57 | $0.54 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.62B | $7.62B | $6.57B | $6.96B |
| Operating Expenses | $7.62B | $10.84B | $10.02B | $10.04B |
| Total Costs & Expenses | $19.14B | $22.37B | $21.08B | $22.11B |
| Interest Income | -$13.75B | $13.75B | $13.49B | $14.19B |
| Interest Expense | -$527.00M | $11.39B | $10.94B | $11.99B |
| Depreciation & Amortization | -$865.00M | $865.00M | $1.65B | $1.27B |
| EBITDA | -$2.73B | $6.41B | $6.55B | $5.49B |
| EBITDA Ratio | $0.21 | $0.23 | $0.25 | $0.21 |
| Operating Income | -$5.54B | $5.54B | $4.91B | $4.22B |
| Operating Income Ratio | $0.43 | $0.20 | $0.19 | $0.16 |
| Other Income/Expenses (Net) | $4.15B | $0.00 | $0.00 | $0.00 |
| Income Before Tax | -$1.39B | $5.54B | $4.91B | $4.22B |
| Income Before Tax Ratio | $0.11 | $0.20 | $0.19 | $0.16 |
| Income Tax Expense | -$254.00M | $1.17B | $1.18B | $995.00M |
| Net Income | -$1.08B | $4.32B | $3.71B | $3.19B |
| Net Income Ratio | $0.08 | $0.15 | $0.14 | $0.12 |
| EPS | -$2.62 | $2.62 | $2.25 | $1.91 |
| Diluted EPS | -$2.60 | $2.60 | $2.22 | $1.88 |
| Weighted Avg Shares Outstanding | $0.00 | $1.58B | $1.58B | $1.59B |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $1.60B | $1.61B | $1.61B |
Over the last four quarters, Morgan Stanley achieved steady financial progress, growing revenue from $26.33B in Q3 2024 to -$12.82B in Q2 2025. Gross profit stayed firm with margins at 128% in Q2 2025 versus 54% in Q3 2024. Operating income totaled -$5.54B in Q2 2025, maintaining a 43% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$2.73B. Net income dropped to -$1.08B, with EPS at -$2.62. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan